Nifty Pharma Today: Index Performance, Stocks and Analysis
- September 9, 2026
- Posted by: Harsh Piplani
- Category: News
Nifty Pharma today closed on a weak note, reflecting broad-based selling across most pharmaceutical stocks in the index. The sector index ended at 26,691.8, down 189 points or 0.7% from the previous close of 26,880.8. The session opened almost flat at 26,881.25, moved to an intraday high of 26,981.15, and then slipped to a low of 26,650.9 before settling near the lower end of the day’s range. That intraday structure matters because it suggests the sector could not hold early levels and sellers remained active through the session.
For users searching Nifty Pharma live, Nifty Pharma performance, Nifty Pharma stocks, top gainers, top losers, and sector breadth, today’s data points to a clearly negative market tone. Out of 20 constituents, only 4 advanced while 16 declined. In other words, weakness was not limited to one or two heavyweights; it was spread across the basket. A 20% green ratio and 80% red ratio reinforce the idea that the fall was broad-based rather than isolated.
This article breaks down Nifty Pharma today using only verified price and breadth data. It covers the index snapshot, market breadth, complete constituent performance, the best and worst-performing pharma stocks, the role of heavyweight shares, practical technical interpretation based on the session’s price action, historical comparison using the available timeframe, and key levels investors may watch from today’s high-low structure. The goal is to help both beginners and experienced market participants understand what happened in the pharma sector and what today’s move may imply.
Nifty Pharma Today: Sector Index Snapshot
| Metric | Value |
|---|---|
| Current Value | 26,691.8 |
| Absolute Change | -189.0 |
| Percentage Change | -0.7% |
| Opening Value | 26,881.25 |
| Previous Close | 26,880.8 |
| Today’s High | 26,981.15 |
| Today’s Low | 26,650.9 |
| Market Status | Closed |
| Last Updated | 9 September 2026 at 4:00:09 PM IST |
| Market Trend | Bearish |
The Nifty Pharma index spent the day under pressure. It opened near the previous close, which usually suggests a neutral start, but it failed to build on the early move. The day’s high of 26,981.15 stayed only modestly above the opening level, while the fall to 26,650.9 showed stronger downside follow-through. Since the close came much closer to the day’s low than the day’s high, the session can be read as bearish from a price-behaviour perspective.
In simple terms, buyers were present briefly, but sellers controlled the broader session. For investors tracking Nifty Pharma today, that combination of a negative close, weak breadth, and a close near the lower end of the range indicates that sentiment within the pharma pack remained cautious throughout the day.
What Happened in Nifty Pharma Today?
The headline move was a 0.7% decline in the sector index, but the deeper message comes from the internal structure of the basket. Several major names ended in the red, and many of the heavyweight stocks also declined. Stocks such as Sun Pharmaceutical Industries, Divi’s Laboratories, Cipla, Dr. Reddy’s Laboratories, Mankind Pharma, Zydus Lifesciences, Torrent Pharmaceuticals, and Abbott India all closed lower. That matters because when both breadth and heavyweight participation turn negative together, index pressure tends to look more durable than a narrow correction.
At the same time, the sector was not uniformly weak. A few counters still managed gains, led by Gland Pharma, followed by Biocon, Aurobindo Pharma, and Natco Pharma. However, the number of gainers was too small to offset the broad decline elsewhere. So while there were pockets of resilience, the larger takeaway is that the pharma sector saw stock-specific strength in a few names but overall weakness at the index level.
Based on available data, today’s interpretation is straightforward: Nifty Pharma fell because the majority of constituent stocks declined, and several widely tracked pharma heavyweights also closed in negative territory. This was primarily a breadth-led and heavyweight-assisted down day.
Market Breadth: How Strong or Weak Was the Pharma Pack?
| Breadth Metric | Value |
|---|---|
| Advancing Stocks | 4 |
| Declining Stocks | 16 |
| Unchanged Stocks | 0 |
| Advance-Decline Ratio | 0.25 |
| Stocks in Green | 20% |
| Stocks in Red | 80% |
Market breadth is one of the simplest and most useful ways to understand sector strength. An advance-decline ratio of 0.25 means there was only one advancing stock for every four declining stocks. That is a weak breadth reading and typically points to broad selling pressure.
The 80% red reading is especially important for traders and investors looking beyond the headline index number. A sector index can sometimes fall because one large stock declines sharply, even if many smaller constituents are stable. That was not the case today. Nifty Pharma weakness was distributed across the basket, which gives the move greater internal confirmation.
From an interpretation standpoint, today’s breadth indicates bearish participation. It does not automatically forecast the next session, but it does tell us that the day’s fall had wide support on the downside. Broad participation in a decline usually carries more analytical significance than a narrow, one-stock drop.
Complete Nifty Pharma Constituent Performance
| Company | CMP | Today’s % | Today’s Change | 52 Week High | 52 Week Low | Trend |
|---|---|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals Ltd. | 2,408.9 | -3.87% | -97.1 | – | – | Bearish |
| Gland Pharma Ltd. | 3,026.2 | 2.26% | 66.9 | – | – | Bullish |
| Mankind Pharma Ltd. | 2,265 | -1.91% | -44 | – | – | Bearish |
| Glenmark Pharmaceuticals Ltd. | 2,435 | -1.6% | -39.5 | – | – | Bearish |
| Zydus Lifesciences Ltd. | 1,127.4 | -1.58% | -18.1 | – | – | Bearish |
| Cipla Ltd. | 1,363.1 | -1.51% | -20.9 | – | – | Bearish |
| Abbott India Ltd. | 25,225 | -1.29% | -330 | – | – | Bearish |
| Ajanta Pharma Ltd. | 3,534.4 | -1.25% | -44.9 | – | – | Bearish |
| Granules India Ltd. | 884.8 | -1.18% | -10.55 | – | – | Bearish |
| Sun Pharmaceutical Industries Ltd. | 1,864.9 | -1.11% | -21 | – | – | Bearish |
| Divi’s Laboratories Ltd. | 9,488 | -0.91% | -87 | – | – | Bearish |
| Alkem Laboratories Ltd. | 5,139 | -0.81% | -42 | – | – | Bearish |
| Biocon Ltd. | 395 | 0.69% | 2.7 | – | – | Bullish |
| Torrent Pharmaceuticals Ltd. | 4,930 | -0.6% | -30 | – | – | Bearish |
| Dr. Reddy’s Laboratories Ltd. | 1,145 | -0.52% | -6 | – | – | Bearish |
| Laurus Labs Ltd. | 1,937 | -0.51% | -9.9 | – | – | Bearish |
| Aurobindo Pharma Ltd. | 1,698.9 | 0.41% | 6.9 | – | – | Bullish |
| Lupin Ltd. | 2,100 | -0.22% | -4.7 | – | – | Bearish |
| Ipca Laboratories Ltd. | 1,963.6 | -0.18% | -3.6 | – | – | Bearish |
| Natco Pharma Ltd. | 826.3 | 0.07% | 0.55 | – | – | Sideways to positive |
The complete constituent table confirms how widespread the pressure was. The top performer was Gland Pharma with a gain of 2.26%, while the worst performer was JB Chemicals & Pharmaceuticals with a drop of 3.87%. Most other stocks clustered in mild-to-moderate losses, showing that the index decline came from a broad set of red counters rather than an extreme collapse in one stock.
Another useful observation is that some of the better-known and often-followed names were also weak. Sun Pharma, Divi’s Laboratories, Cipla, Dr. Reddy’s Laboratories, Lupin, Zydus Lifesciences, and Torrent Pharmaceuticals all ended lower. For anyone monitoring Nifty Pharma stocks today, that pattern points to broad caution across the sector, including in several established names.
Top Gainers in Nifty Pharma Today
| Company | Price Change | % Change | Move Summary |
|---|---|---|---|
| Gland Pharma Ltd. | 66.9 | 2.26% | Strongest gainer in the index and one of the few stocks that stayed firmly positive. |
| Biocon Ltd. | 2.7 | 0.69% | Outperformed the sector despite broad weakness elsewhere. |
| Aurobindo Pharma Ltd. | 6.9 | 0.41% | Managed a positive close while many peers finished in the red. |
| Natco Pharma Ltd. | 0.55 | 0.07% | Ended marginally higher, showing relative stability. |
The gainers list was short, which itself is a signal. When only four stocks advance in a 20-stock index, even strong gains in one or two names usually do not change the broader index direction. Gland Pharma clearly stood out as the day’s strongest positive stock. Biocon and Aurobindo Pharma also added some support, while Natco Pharma finished just above the flat line.
From an analytical point of view, these names showed relative strength. Relative strength does not mean a guaranteed trend change, but it does mean these stocks resisted the broader sector’s weakness better than peers. In a weak breadth session, that can make them notable watchlist names for the next trading day.
Top Losers in Nifty Pharma Today
| Company | Price Change | % Change | Move Summary |
|---|---|---|---|
| JB Chemicals & Pharmaceuticals Ltd. | -97.1 | -3.87% | Sharpest fall in the index and the weakest constituent of the day. |
| Mankind Pharma Ltd. | -44 | -1.91% | Significant decline and underperformed the sector index. |
| Glenmark Pharmaceuticals Ltd. | -39.5 | -1.6% | Weak close after opening at the day’s high. |
| Zydus Lifesciences Ltd. | -18.1 | -1.58% | Closed lower and contributed to the negative sector tone. |
| Cipla Ltd. | -20.9 | -1.51% | Large, widely followed pharma name ending clearly in the red. |
The biggest drag on sentiment came from JB Chemicals & Pharmaceuticals, which fell nearly 4%. Mankind Pharma, Glenmark Pharmaceuticals, Zydus Lifesciences, and Cipla also posted meaningful declines. When a sector’s losers include both mid-sized underperformers and prominent names like Cipla, it usually points to a more convincing negative tone.
Glenmark’s intraday pattern is also notable. It opened at 2,486.9, which was also its day’s high, and then closed at 2,435. That kind of structure often reflects selling pressure from the outset. Similar price patterns across multiple stocks help explain why the overall Nifty Pharma index remained under pressure throughout the day.
Heavyweight Stocks and Their Role in the Index Move
Heavyweights matter because they tend to have a larger influence on index direction. Among the most important pharma names in today’s dataset, the balance was clearly negative. Sun Pharmaceutical Industries Ltd. fell 1.11%, Divi’s Laboratories Ltd. declined 0.91%, Torrent Pharmaceuticals Ltd. slipped 0.6%, Cipla Ltd. lost 1.51%, Dr. Reddy’s Laboratories Ltd. closed down 0.52%, Mankind Pharma Ltd. dropped 1.91%, and Zydus Lifesciences Ltd. fell 1.58%.
Only Aurobindo Pharma Ltd. among the highlighted heavyweights ended positive, up 0.41%. Lupin Ltd. was close to flat but still ended slightly negative. This skew is important. Even without exact contribution weights, the direction of the major stocks strongly suggests that heavyweight weakness reinforced the broader breadth-led decline.
For traders looking at Nifty Pharma analysis, this is a key point: the sector was weak not only because many stocks fell, but also because several of the most influential names did not provide support.
Most Active Pharma Stocks in Focus
The most active and closely watched stocks in today’s available dataset included Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Cipla, Dr. Reddy’s Laboratories, Mankind Pharma, Zydus Lifesciences, Lupin, Abbott India, and Aurobindo Pharma. Activity matters because the stocks that draw the most market attention often shape intraday sentiment for the entire sector.
Among these active counters, the negative side again dominated. Sun Pharma, Divi’s Labs, Torrent Pharma, Cipla, Dr. Reddy’s, Mankind Pharma, Zydus Lifesciences, Lupin, and Abbott India all closed lower. Only Aurobindo Pharma finished in positive territory. That alignment between actively tracked stocks and the negative breadth reading gives extra confirmation to today’s bearish sector narrative.
In practical terms, when most active names are weak along with the broader index, market participants often interpret the move as more meaningful than a quiet, low-conviction decline. Today’s Nifty Pharma action therefore looked like a genuine sector down day rather than random mixed movement.
Technical Interpretation Based on Today’s Price Action
Using only the verified session data, Nifty Pharma today showed a bearish intraday structure. The index opened near the previous close, attempted an early rise to 26,981.15, but failed to sustain that strength. It then moved lower to 26,650.9 and closed at 26,691.8. That means the close was closer to the low than the high, which generally signals that sellers controlled the latter part of the session.
From a practical level-based perspective, today’s low of 26,650.9 becomes an immediate reference zone on the downside because it marks where the market found some support during the session. Likewise, the day’s high of 26,981.15 becomes an immediate near-term overhead reference because it marks the level where upside momentum stalled. These are not long-term support and resistance systems, but they are the cleanest observable session markers from the available data.
The day’s range was 330.25 points, calculated from the high-low spread. That is a meaningful intraday movement for a sector index and suggests active price discovery rather than a flat session. The fact that the index opened near 26,881 and closed about 189 points lower shows a decisive directional bias by the end of the day.
Short-term traders often look at whether an index closes in the upper, middle, or lower part of its intraday range. Nifty Pharma closed in the lower zone of the day’s range, which is typically interpreted as weak short-term momentum. Combined with an 80% red breadth reading, the technical takeaway from today alone remains bearish.
Historical Performance Comparison Based on Available Data
| Period | Performance |
|---|---|
| Today vs Previous Close | -0.7% |
| Absolute Move Today | -189.0 points |
| Open vs Previous Close | Almost flat |
| Close vs Day High | Below high by 289.35 points |
| Close vs Day Low | Above low by 40.9 points |
While broader multi-period return series are not part of the available dataset, the current session still offers useful historical context at the day level. The index effectively started unchanged compared with the previous close but could not hold early stability. That means the day’s weakness developed during the trading session rather than being driven by a large gap-down open.
Another notable point is the closing position. Ending just 40.9 points above the intraday low shows that the final settlement was much closer to the weakest level of the day than the strongest. In market analysis, a close near the low often indicates that selling pressure persisted into the final phase of the session.
So even with only one full session comparison available here, the day tells a clear story: neutral open, failed early upside, broad-based declines across constituents, and a soft close near the low.
What Should Investors Watch Next in Nifty Pharma?
For the next session, the first thing to monitor is whether market breadth improves. After a day with only 4 advancers and 16 decliners, a rebound supported by broader participation would look healthier than a rebound led by only one or two stocks. Breadth is important because it helps distinguish between a temporary bounce and a stronger sector recovery.
Second, investors should track whether today’s positive outliers can sustain relative strength. Gland Pharma was the clear standout, while Biocon, Aurobindo Pharma, and Natco Pharma also stayed positive. If these stocks continue to attract buying while some of the large decliners stabilise, the sector’s internal tone may improve.
Third, heavyweight behaviour remains crucial. Today, many major names such as Sun Pharma, Divi’s Laboratories, Cipla, Dr. Reddy’s Laboratories, Mankind Pharma, Zydus Lifesciences, and Torrent Pharmaceuticals closed lower. If these stocks remain under pressure, Nifty Pharma may struggle to regain momentum even if a few smaller names perform well.
Finally, the session levels themselves are worth watching. The day’s low of 26,650.9 is the most immediate downside marker from today’s trade, while 26,981.15 is the nearest observed upside barrier from the same session. Whether the index holds above the low or reclaims the high zone will shape the short-term price narrative.
Key Takeaways
- Nifty Pharma closed at 26,691.8, down 189 points or 0.7%.
- The sector opened near flat but weakened through the day and closed near the intraday low.
- Market breadth was weak: 4 advancers, 16 decliners, and an advance-decline ratio of 0.25.
- Gland Pharma was the top gainer, rising 2.26%.
- JB Chemicals & Pharmaceuticals was the top loser, falling 3.87%.
- Several key pharma heavyweights, including Sun Pharma, Divi’s Labs, Cipla, Dr. Reddy’s, Mankind Pharma, Zydus Lifesciences, and Torrent Pharma, ended lower.
- Only a handful of stocks provided support, including Gland Pharma, Biocon, Aurobindo Pharma, and Natco Pharma.
- Based on available price and breadth data, the session trend was bearish.
Featured Snippet Ready Answers
What is Nifty Pharma? Nifty Pharma is a sectoral stock market index that tracks selected pharmaceutical companies listed on the NSE. It helps investors understand how the Indian pharma sector is performing as a group.
Why is Nifty Pharma moving today? Nifty Pharma moved lower today because most of its constituent stocks declined. Out of 20 stocks, 16 closed in the red, and several major pharma names also ended lower.
Which stock contributed the most strength today? Based on percentage performance, Gland Pharma was the strongest stock in Nifty Pharma today, rising 2.26%.
Which stock fell the most today? JB Chemicals & Pharmaceuticals was the worst-performing Nifty Pharma stock today, declining 3.87%.
How many Nifty Pharma stocks advanced today? Four Nifty Pharma stocks advanced today, while sixteen declined.
Google AI Overview Style Summary
Nifty Pharma closed lower on 9 September 2026, ending at 26,691.8, down 0.7% or 189 points. The decline was broad-based, with 16 of 20 constituent stocks closing in the red and only 4 ending higher. The session opened near flat, briefly touched 26,981.15, then weakened and settled close to the day’s low of 26,650.9, indicating bearish intraday momentum.
The fall was driven by widespread weakness across the sector, including declines in major pharma names such as Sun Pharmaceutical Industries, Divi’s Laboratories, Cipla, Dr. Reddy’s Laboratories, Mankind Pharma, Zydus Lifesciences, and Torrent Pharmaceuticals. On the positive side, Gland Pharma led gainers with a 2.26% rise, followed by Biocon, Aurobindo Pharma, and Natco Pharma.
Investors may next watch whether breadth improves, whether heavyweight stocks stabilise, and whether the index holds above today’s low or attempts to reclaim the day’s high zone.
Published on 9 September 2026 at 4:06 PM IST
Know more with Univest
Log in to Univest to explore market insights, track stocks, and get 3 free trade ideas on Share Market Today.
Frequently Asked Questions
1. What is Nifty Pharma today?
Nifty Pharma today closed at 26,691.8, down 189 points or 0.7%.
2. Why did Nifty Pharma fall today?
Nifty Pharma fell because the majority of its constituent stocks declined. Sixteen of the 20 stocks in the index closed in the red.
3. Is Nifty Pharma bullish or bearish today?
Based on today’s price action and breadth, the session trend was bearish.
4. How many Nifty Pharma stocks advanced today?
Four stocks advanced in Nifty Pharma today.
5. How many Nifty Pharma stocks declined today?
Sixteen stocks declined in Nifty Pharma today.
6. What was the advance-decline ratio in Nifty Pharma today?
The advance-decline ratio was 0.25, meaning there was one advancing stock for every four declining stocks.
7. Which was the top gainer in Nifty Pharma today?
Gland Pharma was the top gainer, rising 2.26% to 3,026.2.
8. Which was the top loser in Nifty Pharma today?
JB Chemicals & Pharmaceuticals was the top loser, falling 3.87% to 2,408.9.
9. What were the high and low levels of Nifty Pharma today?
Nifty Pharma touched a high of 26,981.15 and a low of 26,650.9 during the session.
10. Which heavyweight pharma stocks were weak today?
Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Cipla, Dr. Reddy’s Laboratories, Mankind Pharma, Zydus Lifesciences, Lupin, and Abbott India all ended lower.
11. Which pharma stocks closed higher today?
Gland Pharma, Biocon, Aurobindo Pharma, and Natco Pharma closed higher today.
12. What should investors watch next in Nifty Pharma?
Investors can watch whether breadth improves, whether heavyweight stocks stabilise, and how the index behaves around today’s high and low levels.
Disclaimer
Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.
